All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel 
.
| Security |
Imputed
Share Price |
Prev
Shares |
Current
Shares |
Change
(Percent) |
Prev Value
(USD x1000) |
Current Value
(USD x1000) |
Change
(Percent) |
|---|
| SLRX / Salarius Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| CNC / Centene Corporation
|
|
|
|
|
|
|
|
| CRTX / Cortexyme Inc Put
|
|
|
|
|
|
|
|
| LOGC / ContextLogic Holdings Inc.
|
|
|
|
|
|
|
|
| CCRN / Cross Country Healthcare, Inc.
|
|
|
|
|
|
|
|
| CBAY / CymaBay Therapeutics, Inc.
|
|
|
|
|
|
|
|
| MIRM / Mirum Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| MBRX / Moleculin Biotech, Inc.
|
|
|
|
|
|
|
|
| AGLE / Aeglea BioTherapeutics Inc
|
|
|
|
|
|
|
|
| EPIX / ESSA Pharma Inc.
|
|
|
|
|
|
|
|
| AMGN / Amgen Inc.
|
|
|
|
|
|
|
|
| SYRS / Syros Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| CAH / Cardinal Health, Inc.
|
|
|
|
|
|
|
|
| MGNX / MacroGenics, Inc.
|
|
|
|
|
|
|
|
| CBIO / Crescent Biopharma, Inc.
|
|
|
|
|
|
|
|
| AVAH / Aveanna Healthcare Holdings Inc.
|
|
|
|
|
|
|
|
| IDYA / IDEAYA Biosciences, Inc.
|
|
|
|
|
|
|
|
| CHRS / Coherus Oncology, Inc.
|
|
|
|
|
|
|
|
| HLF / Herbalife Ltd.
|
|
|
|
|
|
|
|
| LPTX / Cypherpunk Technologies Inc.
|
|
|
|
|
|
|
|
| ASLN / ASLAN Pharmaceuticals Limited - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| SEER / Seer, Inc.
|
|
|
|
|
|
|
|
| CVRX / CVRx, Inc.
|
|
|
|
|
|
|
|
| HZNP / Horizon Therapeutics Plc
|
|
|
|
|
|
|
|
| BCEL / Atreca, Inc.
|
|
|
|
|
|
|
|
| CHAQ.U / Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of , and one
|
|
|
|
|
|
|
|
| ASGN / ASGN Incorporated
|
|
|
|
|
|
|
|
| FULC / Fulcrum Therapeutics, Inc.
|
|
|
|
|
|
|
|
| GOSS / Gossamer Bio, Inc.
|
|
|
|
|
|
|
|
| KURA / Kura Oncology, Inc.
|
|
|
|
|
|
|
|
| MEIP / MEI Pharma, Inc.
|
|
|
|
|
|
|
|
| NARI / Inari Medical, Inc.
|
|
|
|
|
|
|
|
| RDUS / Radius Recycling, Inc.
|
|
|
|
|
|
|
|
| EVLO / Evelo Biosciences, Inc. Put
|
|
|
|
|
|
|
|
| / PHILLIPS EDISON & CO INC
|
|
|
|
|
|
|
|
| AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| ASND / Ascendis Pharma A/S Put
|
|
|
|
|
|
|
|
| RCOR.WS / Renovacor, Inc. Warrants, enti Warrants, entitling the holder thereof to purchase one-half (1/2) of a share of common stock at a price of $11.50 per whole share
|
|
|
|
|
|
|
|
| SOLY / Soliton Inc
|
|
|
|
|
|
|
|
| SPRB / Spruce Biosciences, Inc.
|
|
|
|
|
|
|
|
| MRSN / Mersana Therapeutics, Inc.
|
|
|
|
|
|
|
|
| HRC / Hill-Rom Holdings Inc
|
|
|
|
|
|
|
|
| SYNH / Syneos Health Inc - Class A
|
|
|
|
|
|
|
|
| NLTX / Neoleukin Therapeutics, Inc.
|
|
|
|
|
|
|
|
| AFMD / Affimed N.V.
|
|
|
|
|
|
|
|
| HCA / HCA Healthcare, Inc.
|
|
|
|
|
|
|
|
| MEOBF / Mesoblast Limited Put
|
|
|
|
|
|
|
|
| GILD / Gilead Sciences, Inc.
|
|
|
|
|
|
|
|
| CYCC / Bio Green Med Solution, Inc.
|
|
|
|
|
|
|
|
| UTHR / United Therapeutics Corporation
|
|
|
|
|
|
|
|
| VINC / Vincerx Pharma, Inc.
|
|
|
|
|
|
|
|
| CMAX / CareMax, Inc.
|
|
|
|
|
|
|
|
| GLD / SPDR Gold Shares
|
|
|
|
|
|
|
|
| HQY / HealthEquity, Inc.
|
|
|
|
|
|
|
|
| DTIL / Precision BioSciences, Inc.
|
|
|
|
|
|
|
|
| ALBO / Albireo Pharma Inc
|
|
|
|
|
|
|
|
| CMAXW / CareMax Inc - Warrants (08/06/2026)
|
|
|
|
|
|
|
|
| ITGR / Integer Holdings Corporation
|
|
|
|
|
|
|
|
| AMN / AMN Healthcare Services, Inc.
|
|
|
|
|
|
|
|
| ARNA / Arena Pharmaceuticals Inc
|
|
|
|
|
|
|
|
| VRTX / Vertex Pharmaceuticals Incorporated
|
|
|
|
|
|
|
|
| AYLA / Ayala Pharmaceuticals Inc
|
|
|
|
|
|
|
|
| RUBY / Rubius Therapeutics, Inc.
|
|
|
|
|
|
|
|
| NTUS / Natus Medical Inc
|
|
|
|
|
|
|
|
| CI / The Cigna Group
|
|
|
|
|
|
|
|
| SRRA / Sierra Oncology Inc
|
|
|
|
|
|
|
|
| MCK / McKesson Corporation
|
|
|
|
|
|
|
|
| UHS / Universal Health Services, Inc.
|
|
|
|
|
|
|
|
| CHAQ / Chardan Healthcare Acquisition 2 Corp
|
|
|
|
|
|
|
|
| NBSE / NeuBase Therapeutics, Inc.
|
|
|
|
|
|
|
|
| GLPG / Galapagos NV - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| HSAQ / Health Sciences Acquisitions Corp 2
|
|
|
|
|
|
|
|
| EUCRU / Eucrates Biomedical Acquisition Corp
|
|
|
|
|
|
|
|
| XFOR / X4 Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| ARDX / Ardelyx, Inc.
|
|
|
|
|
|
|
|
| CRIS / Curis, Inc.
|
|
|
|
|
|
|
|
| RIGL / Rigel Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| MRK / Merck & Co., Inc.
|
|
|
|
|
|
|
|
| HUMAW / Humacyte, Inc. - Equity Warrant
|
|
|
|
|
|
|
|
| FUSN / Fusion Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
| PTGX / Protagonist Therapeutics, Inc.
|
|
|
|
|
|
|
|
| VKTX / Viking Therapeutics, Inc.
|
|
|
|
|
|
|
|
| PRQR / ProQR Therapeutics N.V.
|
|
|
|
|
|
|
|
| NYXH / Nyxoah SA
|
|
|
|
|
|
|
|
| TVTX / Travere Therapeutics, Inc.
|
|
|
|
|
|
|
|
